These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 19378227

  • 1. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
    Burger CD.
    COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
    [Abstract] [Full Text] [Related]

  • 2. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S, Samoyeau R, Weitzenblum E.
    Blood Press Suppl; 1995 Apr; 3():47-57. PubMed ID: 8535542
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The effect of amlodipine on exercise-induced pulmonary hypertension and right heart function in patients with chronic obstructive pulmonary disease.
    Franz IW, Van Der Meyden J, Schaupp S, Tönnesmann U.
    Z Kardiol; 2002 Oct; 91(10):833-9. PubMed ID: 12395224
    [Abstract] [Full Text] [Related]

  • 5. Cor pulmonale.
    Weitzenblum E, Chaouat A.
    Chron Respir Dis; 2009 Oct; 6(3):177-85. PubMed ID: 19643833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pulmonary hypertension associated with chronic obstructive pulmonary disease.
    Chhabra SK.
    Indian J Chest Dis Allied Sci; 2010 Oct; 52(1):29-40. PubMed ID: 20364612
    [Abstract] [Full Text] [Related]

  • 8. Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension.
    Wang L, Jin YZ, Zhao QH, Jiang R, Wu WH, Gong SG, He J, Liu JM, Jing ZC.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct; 12():3353-3360. PubMed ID: 29200842
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pulmonary hypertension in chronic obstructive pulmonary disease.
    Weitzenblum E, Chaouat A, Kessler R.
    Pneumonol Alergol Pol; 2013 Oct; 81(4):390-8. PubMed ID: 23744170
    [Abstract] [Full Text] [Related]

  • 12. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
    Corte TJ, Wort SJ.
    Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic polymorphisms of the serotonin transporter, but not the 2a receptor or nitric oxide synthetase, are associated with pulmonary hypertension in chronic obstructive pulmonary disease.
    Ulrich S, Hersberger M, Fischler M, Nussbaumer-Ochsner Y, Treder U, Russi EW, Speich R.
    Respiration; 2010 Mar; 79(4):288-95. PubMed ID: 19556740
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary hypertension in COPD: pathophysiology and therapeutic targets.
    Zakynthinos E, Daniil Z, Papanikolaou J, Makris D.
    Curr Drug Targets; 2011 Apr; 12(4):501-13. PubMed ID: 21194405
    [Abstract] [Full Text] [Related]

  • 16. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.
    Barberà JA, Blanco I.
    Drugs; 2009 Jun 18; 69(9):1153-71. PubMed ID: 19537834
    [Abstract] [Full Text] [Related]

  • 17. [Pulmonary hypertension in chronic respiratory and cardiac diseases].
    Cordier JF.
    Rev Prat; 2008 Nov 30; 58(18):2019-23. PubMed ID: 19143273
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.